• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION PRECISEPRO RX US CAROTID SYSTE; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION PRECISEPRO RX US CAROTID SYSTE; STENT, CAROTID Back to Search Results
Model Number PC0730RXC
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/08/2020
Event Type  malfunction  
Manufacturer Narrative
A review of the manufacturing documentation associated with this lot presented no issues during the manufacturing process that can be related to the reported complaint.It is unknown if the device will be returned for testing and evaluation.   additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, the 7mm x 30mm precise pro rapid exchange (rx) carotid stent system couldn't be delivered to the target site then the doctor found the tip was ripped and fragmented.There was no reported patient injury.The device was opened in sterile field.The device was contaminated but will be returned for evaluation.
 
Manufacturer Narrative
This device is available for analysis but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, the 7mm x 30mm precise pro rapid exchange (rx) carotid stent system couldn't be delivered to the target site then the doctor found the tip was ripped and fragmented.There was no reported patient injury.The device was opened in sterile field.The damage was noted during use inside the patient.When removed from the tray, the stent was still constrained within the outer member/sheath.The product was stored and handled according to the instructions for use (ifu).The product was inspected and prepped according to the ifu.There was nothing unusual noted about the stent delivery system prior to use.A non-cordis 7f sheath introducer was used.A non-cordis 7f guiding catheter was used.The device was contaminated but will be returned for evaluation.
 
Manufacturer Narrative
Complaint conclusion: a precise pro rapid exchange (rx) 7mm x 30mm carotid stent system couldn't be delivered to the target site, then the doctor found that the tip was ripped and fragmented.The device was opened in a sterile field.The damage was noted during use inside the patient.When removed from the tray, the stent was still constrained within the outer member/sheath.The product was stored and handled according to the instructions for use (ifu).The product was inspected and prepped according to the ifu.There was nothing unusual noted about the stent delivery system prior to use.A non-cordis 7f sheath introducer was used.A non-cordis 7f guiding catheter was used.There was no reported patient injury.One non-sterile precisepro rx us carotid system was received for analysis inside a plastic bag.No original packaging was returned.The valve of the unit was received partially locked.Per visual analysis, stent was observed deployed from the unit approximately 1.5 mm.Also, the body/catheter of the unit was observed kinked approximately at 0.6 cm from the strain relief.The tip of the catheter was observed placed on the catheter and no anomalies were observed on it.No other anomalies were observed.Per functional analysis, deployment test was performed successfully; neither resistance nor any anomalies were observed during the test.No damages were observed on the stent.A product history record (phr) review of lot 17916479 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿catheter tip - separated - in patient¿ was not confirmed since the tip of the catheter was observed placed on the catheter and no damages/anomalies were observed on it.Also, the stent was observed deployed approximately 1.5 mm from the unit, as received.Additionally, a deployment test was performed successfully; neither resistance nor any anomalies were observed during the test.Nevertheless, the cause of the pre-deployment and the kinked condition observed on the unit, could not be conclusively determined.However, it is probable that procedural and or handling factors such as the user¿s interaction with the device and vessel characteristics (although unknown) may have led to the reported event as well as the observed kinked condition and pre-deployment condition on the device, as received.According to the instructions for use, which are not intended as a mitigation of risk, ¿extract the stent delivery system from the tray.Examine the device for any damage.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.Verify that the delivery system¿s radiopaque inner shaft markers (leading and trailing ends) are proximal and distal to the target lesion.B.Unlock the tuohy borst valve connecting the inner shaft and outer sheath of the delivery system.C.Ensure that the access sheath or guiding catheter does not move during deployment.D.Initiate stent deployment by retracting the outer sheath while holding the inner shaft in a fixed position.Deployment is complete when the outer sheath marker passes the proximal inner shaft stent marker.Note: the mechanism for stent deployment is outer sheath retraction.Deployment is completed by maintaining inner shaft position while retracting the outer sheath and allowing the stent to expand (often referred to as the ¿pin-and-pull¿ method).Note: if resistance is met during delivery system introduction, the system should be withdrawn and another system should be used.Note: if any resistance is met during delivery system withdrawal, advance the outer sheath until the outer sheath marker contacts the catheter tip and withdraw the system as one unit.¿ neither the phr review nor the product analysis suggests that the event experienced by the customer could be related to the manufacturing process; therefore, no corrective/preventive action will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISEPRO RX US CAROTID SYSTE
Type of Device
STENT, CAROTID
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60 avenue
miami lakes FL 33014
MDR Report Key10896624
MDR Text Key218269429
Report Number9616099-2020-04081
Device Sequence Number1
Product Code NIM
UDI-Device Identifier20705032036457
UDI-Public20705032036457
Combination Product (y/n)N
PMA/PMN Number
P030047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 01/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/24/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2021
Device Model NumberPC0730RXC
Device Catalogue NumberPC0730RXC
Device Lot Number17916479
Was Device Available for Evaluation? Yes
Date Manufacturer Received01/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age76 YR
-
-